Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Expected to Reach $912 million by 2023 – NOVARTIS, ALLERGAN, ELLEX, GLAUKOS, ISTAR, IVANTIS, LUMENIS

The Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market was valued at $144 million in 2016, and is expected to reach $912 million by 2023, registering a CAGR of 30.1% from 2017 to 2023.

Minimally invasive glaucoma surgery (MIGS) devices can be are employed in any glaucoma surgery that avoids conjunctival dissection, and includes an ab interno incision for the treatment of patients suffering from glaucoma. The advent of MIGS devices has transformed the patients care with mild-to-moderate glaucoma conditions. In addition, improved safety profile as well as less time required for recovery after surgery as compared to more invasive techniques increases the demand for MIGS devices. This propels manufacturers to introduce efficient MIGS devices such as stents, shunts, and minimally invasive implants in the market. Moreover, glaucoma is the primary cause of irreversible blindness across the globe, and it was estimated that around 4% of the global population suffered from glaucoma in 2014. This has increased the demand for MIGS devices in the treatment of glaucoma.

Get Sample Copy at: https://www.premiummarketinsights.com/sample/AMR00013701

Key Benefits
The study provides an in-depth analysis with the current trends and future estimations of the global minimally invasive glaucoma surgery (MIGS) devices market to elucidate the imminent investment pockets.
Comprehensive analysis of the factors that drive and restrict the market growth is provided.
The quantitative analysis of the industry from 2016 to 2023 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of key segments of the industry is provided to understand the types of minimally invasive glaucoma surgery (MIGS) devices used globally.
Key players and their strategies are analyzed to understand the competitive outlook of the market.

Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Key Segments:
By Surgery
Glaucoma in Conjunction with Cataract
Stand Alone Glaucoma

Ask for Discount at: https://www.premiummarketinsights.com/discount/AMR00013701                                    

Table of Content:

1 Introduction
1.1 Scope of Study
2 Key Takeaways
3 Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Landscape
3.1 Market Overview
3.2 Market Segmentation
3.3 PEST Analysis
4 Minimally Invasive Glaucoma Surgery (MIGS) Devices Market - Key Industry Dynamics
4.1 Key Market Drivers
4.2 Key Market Restraints
4.3 Key Market Opportunities
4.4 Future Trends
4.5 Impact Analysis
5  Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis- Global
5.1 Global   Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
5.2 Global   Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Forecasts and Analysis
5.3 Market Positioning/Market Share
5.4 Performance of Key Players
5.5 Expert Opinions   Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

Get Complete Report at: https://www.premiummarketinsights.com/buy/AMR00013701

Contact Info:
Name: Sameer Joshi
Email: [email protected]
Organization: Premium Market Insights
Phone: +1-646-491-9876

About Premium Market Insights:

Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries. Our commitment to customer service is best exemplified by free analyst support that we offer to our clients which sets us apart from any other provider.

Posted by on Monday August 19 2019, 5:47 AM EDT. All trademarks acknowledged. Filed under Biotechnology, Business Services, Diagnostics, Featured Press Release, Healthcare, Life Sciences, Medical Devices, Pharmaceuticals. Comments and Trackbacks closed. Follow responses: RSS 2.0

Comments are closed

News Categories

Featured Press Releases

Log in